Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/22/25 17:00 | 5/20/25 | SPRY | Health | Drug | Pharmaceutical Preparations | Fitzpatrick Alexander A | CA | O | GC | 1 | S.d | -1,452 | 14.10 | 0 | -103 | 90 | D | |||||||||||||||
5/22/25 17:00 | 5/20/25 | SPRY | Health | Drug | Pharmaceutical Preparations | Saunders Brent L | CA | D | 1 | S.d | -1,710 | 14.25 | 0 | -120 | -100 | 0 | D | |||||||||||||||
5/22/25 17:00 | 5/20/25 | SPRY | Health | Drug | Pharmaceutical Preparations | Scott Kathleen D. | CA | O | CFO | 1 | S.d | -705 | 14.10 | 0 | -50 | 16 | D | |||||||||||||||
4/8/25 16:45 | 4/7/25 | SPRY | Health | Drug | Pharmaceutical Preparations | Shawver Laura | CA | D | 1 | S.d | -615 | 12.30 | 0 | -50 | 210 | D | ||||||||||||||||
3/21/25 18:30 | 3/20/25 | SPRY | Health | Drug | Pharmaceutical Preparations | Karas Eric | CA | O | Chief Co | 1 | S.d | -140 | 14.00 | 0 | -10 | 8 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |